Business Case Studies, Diversification Strategies Case Study, Merck KGaA's, Focused Diversification Strategy

print page
Tell A Friend
Bookmark
 

Case Categories

Diversification Strategies Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Merck KGaA's 'Focused Diversification Strategy': The Prospects and Perils

Publication Year : 2006

Authors: Kalyani, Sumit Kumar Chaudhuri

Industry: Health Care

Region:USA Germany

Case Code: DIS0011

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
Traditionally, the global pharmaceutical industry has leveraged on its blockbuster model to become one of the most profitable industries in the world. However, since the 1990s, the industry has been witnessing a rapid growth in the generic drug business worldwide and to add to its woes even with increasing investments in R&D, drug innovations have declined. It is opined that the industry is heading towards a consolidation and this prompted Merck KGaA, a German pharmaceutical group, to bid for another German company, Schering AG. However, Schering refused the bid on the grounds that Merck had underestimated its value.

Pedagogical Objectives:

  • To understand the reasons and consequences of the changing business model of the global pharmaceutical industry
  • To discuss the probable synergies that Merck might accrue by acquiring Schering.

Keywords : Blockbuster model of global pharmaceutical industry; Growth of generic drugs; Consolidation in the global pharmaceutical industry; Decline in drug innovations; Increasing costs of drug innovations; Traditional drug manufacturers going generic; Constraints of new drug research; Diversification Strategies Case Study; Patent expires of blockbuster drugs; Rise of generic drug manufacturers

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • Kai Alexander SchlevogtKai Alexander Schlevogt

    Professor of international strategy and leadership at the National University of Singapore Business School. He serves as a Program Director of the Nestle Global Leadership Program, delivered in association with London Business School.
    Speaks on The China Factor
  • Al RiesAl Ries

    Chairman of Ries, an Atlanta-based marketing strategy firm
    Speaks on Brands and Branding
  • Derek W BunnDerek W Bunn

    Professor at London Business School.
    Speaks on Decision Making
  • View All Executive Interviews»






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap